Peptides Studied for Gut Health
Gut health is one of the most active areas of peptide research in animal models — and one of the most frustrating in terms of human evidence. BPC-157, originally isolated from human gastric juice, has been studied extensively in animal models of ulcers, inflammatory bowel conditions, and gut lining repair. The animal data is genuinely impressive, but human clinical evidence is limited to a handful of small studies.
KPV is a tripeptide fragment of alpha-MSH with anti-inflammatory properties studied primarily in animal colitis models. A landmark study in Gastroenterology showed oral KPV reduced intestinal inflammation in mice — but there are zero human clinical trials to date.
Both peptides show real mechanistic promise for GI conditions, but anyone considering them should understand exactly how far the evidence extends — and where it stops.
BPC-157
Body Protection Compound-157
A synthetic pentadecapeptide studied for tissue repair, gut healing, and recovery. Extensive animal data, very limited human evidence.
KPV
Lys-Pro-Val (Alpha-MSH Fragment)
The smallest bioactive peptide in our database — just 3 amino acids. A fragment of alpha-MSH with anti-inflammatory properties, gaining traction for gut health. Promising animal colitis data, but zero human clinical trials.